Summary
Recommends that VHA define permissible clinical uses and oversight of general-purpose generative AI chat tools, assess whether high-impact AI safeguards should apply, and integrate AI-related risk monitoring and staff reporting into patient safety programs.
Healthcare Implications
Calls for VHA governance and quality assurance for AI used in clinical care and documentation. VHA concurred in principle with the first recommendation and concurred with the other two, with action plans targeting April 2027. These are oversight recommendations and planned responses, not an independently enforceable clinical standard.